Author:
Rakovskaia Tatiana,Oboroc Sandu,Bacinschi Nicolae
Reference32 articles.
1. Agustí A, Celli BR, Criner GJ, Halpin D, Anzueto A, Barnes P, Bourbeau J, Han MK, Martinez FJ, Montes de Oca M, Mortimer K, Papi A, Pavord I, Roche N, Salvi S, Sin DD, Singh D, Stockley R, López Varela MV, Wedzicha JA, Vogelmeier CF. Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary. Eur Respir J. 2023 Apr 1;61(4):2300239.
2. Ariel A, Barnes PJ, Maricoto T, Román-Rodríguez M, Powell A, Quint JK. Rational use of inhaled corticosteroids for the treatment of COPD: a plain language summary. J Comp Eff Res. 2023 Dec;12(12):e230136.
3. Bacinschi N, Vasilache E, Caracaş A. Eficacitatea şi inofensivitatea bronhodilatatoarelor în bronhopneumopatia obstructivă cronică. Buletinul Academiei de Ştiinţe a Moldovei. 2019;3(63):266-271.
4. Barnes PJ. Theophylline. Pharmaceuticals (Basel). 2010 Mar 18;3(3):725-747.
5. Burkes RM, Panos RJ. Ultra Long-Acting β-Agonists in Chronic Obstructive Pulmonary Disease. J Exp Pharmacol. 2020 Dec 14;12:589-602.